Amorphous MnO2 Supported on CN@SiO2 for Levofloxacin Degradation via a Non-Radical Pathway by PMS Activation
Abstract
Mn-based catalysts have been extensively studied in advanced oxidation processes based on peroxymonosulfate (PMS) oxidants, demonstrating their significant potential for treating antibiotic-contaminated wastewater. In this study, an amorphous MnO2-based composite catalyst (MnO2/CN@SiO2) was prepared and used to activate PMS for degrading levofloxacin (LEV). The effects of reaction conditions, such as reaction temperature, catalyst dosage, PMS concentration, and solution pH, on LEV degradation were comprehensively investigated. The interference of water components, e.g., NO3−, SO42−, Cl−, CO32−, and humic acid, on the degradation efficiency of LEV was analyzed, and the stability of the catalysts was explored by cycling experiments. Finally, radical quenching experiments and electron paramagnetic resonance spectroscopy were employed to elucidate the contribution of active species to the degradation reaction process. A non-radical-based pathway for LEV degradation was proposed based on these results.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.